A major new study examining the 2023-2024 COVID-19 vaccines shows moderate protection that works best in the first few months but weakens considerably over time. The research, published in JAMA ...
Austin’s growing fleet of autonomous vehicles highlights safety issues and enforcement challenges, as officials and companies weigh long‑term gains against day‑to‑day risks.
Kevin Ma, PhD, discusses new data showing 2024–2025 COVID-19 vaccines reduced hospitalization and severe outcomes. In this Q&A, lead study author Kevin Ma, PhD, an epidemic intelligence service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results